West Deptford, 8086, NJ,
United States
Akers Biosciences Technographics
Akers Biosciences Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Akers Biosciences and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 13 Akers Biosciences employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Akers Biosciences has purchased the following applications: Oracle NetSuite ERP for ERP Financial in 2016, GoDaddy for Application Hosting and Computing Services in 2015 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Akers Biosciences is running and its propensity to invest more and deepen its relationship with Oracle , GoDaddy , Amazon Web Services (AWS) or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Akers Biosciences revenues, which have grown to $2.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Akers Biosciences intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Akers Biosciences Tech Stack and Enterprise Applications
Akers Biosciences ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle NetSuite ERP | ERP Financial | ERP | n/a | 2016 | 2017 |
In 2016, Akers Biosciences implemented Oracle NetSuite ERP to centralize core financial operations. The deployment targeted ERP Financial capability for the company, consolidating accounting, close and reporting workflows for a 13 person life sciences organization based in the United States.
Implementation work focused on configuring Oracle NetSuite ERP general ledger, accounts payable, accounts receivable, fixed asset accounting, period close controls, and financial reporting modules, aligning chart of accounts and audit trail capabilities with public company reporting requirements. The configuration profile and implementation scope included accounting and audit posture adjustments typical of an ERP Financial deployment, with project costs recorded under professional services and accounting fees.
Operational coverage extended across finance, accounting, executive management, and corporate governance functions, changing how financial close, external audit preparation, and board reporting were executed. The company disclosed that increased professional service expenses were linked to implementation activity, and that configuration and implementation expenses for the planned NetSuite Financial System contributed to higher accounting service costs.
For the three months ended September 30, 2018, Akers Biosciences reported a 29% increase in personnel expenses driven by higher salaries, wages and bonuses which rose to $249,445 from 2017, $172,587, while employee benefit expenses declined. Professional service costs rose 127% for the same period with legal fees increasing to $394,067 from 2017, $258,026 and accounting and audit expenses increasing to $206,374 from 2017, $36,130, outcomes described as principally connected to the Board investigation, the resulting restatement of previously issued financials, litigation matters, and the NetSuite configuration and implementation work.
|
Akers Biosciences IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| GoDaddy | Legacy | GoDaddy | Application Hosting and Computing Services | IaaS | n/a | 2015 | 2015 |
In 2015 Akers Biosciences deployed GoDaddy to provide Application Hosting and Computing Services for its public corporate website. The GoDaddy implementation functions as the primary web hosting and domain management platform for Akers Biosciences, supporting content delivery, DNS management, SSL certificate provisioning and basic web server hosting consistent with a 13 employee life sciences firm.
Configuration and administration are centered on GoDaddy control panel management, with site updates and certificate lifecycle tasks handled by internal staff responsible for the company website. This implementation positions GoDaddy as the Application Hosting and Computing Services provider for Akers Biosciences, governing the company's public web presence and customer facing information delivery in the United States.
|
|
|
|
|
Content Delivery Network | IaaS |
|
2016 | 2016 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Akers Biosciences
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
Chief Executive Officer & interim Chief Financial Officer | CXO | Finance | |
|
|
|
Vice President, Finance | VP | Finance | |
|
|
|
Controller | Director | Finance | |
|
Apps Being Evaluated by Akers Biosciences Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||